Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krish Patel

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Nature Cancer|January 6, 2026
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trialPaolo Strati, Lori Leslie, Parveen Shiraz, et al.
Frontiers in Cardiovascular Medicine|December 29, 2025
Temporal trends in mortality involving atrial fibrillation and rheumatic heart disease: a 25-year nationwide analysisMohamed Fawzi Hemida, Maryam Saghir, Alyaa Ahmed Ibrahim, et al.
Leukemia Research|January 27, 2020
A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort studyMax J Gordon, Andrea Sitlinger, Tareq Salous, et al.
The Lancet. Haematology|July 3, 2025
Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 studyPaolo Strati, Januario Castro, Aaron Goodman, et al.
Lancet (London, England)|January 11, 2025
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trialArmin Ghobadi, Veronika Bachanova, Krish Patel, et al.
Transplantation and Cellular Therapy|February 28, 2026
Outpatient Versus Inpatient Axicabtagene Ciloleucel CAR T-Cell Therapy in Non-Hodgkin's Lymphoma: Insights from a US Multicenter Transplant and Cellular Therapy NetworkMinoo Battiwalla, Shanna Arnold Egloff, Gita Nadimpalli, et al.
Blood Advances|November 19, 2024
Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLLJacob D Soumerai, Jacqueline Barrientos, Inhye Ahn, et al.
Cancer|April 9, 2026
Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025Alexey V Danilov, Catherine C Coombs, Tycel Phillips, et al.
Frontiers in Cardiovascular Medicine|May 29, 2026
Opioid overdose and cardiovascular disease-related mortality: a retrospective analysis using real-world data from the USA, 1999-2023Mohamed Fawzi Hemida, Alyaa Ahmed Ibrahim, Maryam Saghir, et al.
Geroscience|April 1, 2025
Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screeningRoland Patai, Krish Patel, Boglarka Csik, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Nature Cancer|January 6, 2026
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trialPaolo Strati, Lori Leslie, Parveen Shiraz, et al.
Frontiers in Cardiovascular Medicine|December 29, 2025
Temporal trends in mortality involving atrial fibrillation and rheumatic heart disease: a 25-year nationwide analysisMohamed Fawzi Hemida, Maryam Saghir, Alyaa Ahmed Ibrahim, et al.
Leukemia Research|January 27, 2020
A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort studyMax J Gordon, Andrea Sitlinger, Tareq Salous, et al.
The Lancet. Haematology|July 3, 2025
Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 studyPaolo Strati, Januario Castro, Aaron Goodman, et al.
Lancet (London, England)|January 11, 2025
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trialArmin Ghobadi, Veronika Bachanova, Krish Patel, et al.
Transplantation and Cellular Therapy|February 28, 2026
Outpatient Versus Inpatient Axicabtagene Ciloleucel CAR T-Cell Therapy in Non-Hodgkin's Lymphoma: Insights from a US Multicenter Transplant and Cellular Therapy NetworkMinoo Battiwalla, Shanna Arnold Egloff, Gita Nadimpalli, et al.
Blood Advances|November 19, 2024
Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLLJacob D Soumerai, Jacqueline Barrientos, Inhye Ahn, et al.
Cancer|April 9, 2026
Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025Alexey V Danilov, Catherine C Coombs, Tycel Phillips, et al.
Frontiers in Cardiovascular Medicine|May 29, 2026
Opioid overdose and cardiovascular disease-related mortality: a retrospective analysis using real-world data from the USA, 1999-2023Mohamed Fawzi Hemida, Alyaa Ahmed Ibrahim, Maryam Saghir, et al.
Geroscience|April 1, 2025
Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screeningRoland Patai, Krish Patel, Boglarka Csik, et al.
Pageof 7